WallStSmart
RXST

Rxsight Inc

NASDAQ: RXST · HEALTHCARE · MEDICAL DEVICES

$6.81
-5.02% today

Updated 2026-04-29

Market cap
$295.88M
P/E ratio
P/S ratio
2.20x
EPS (TTM)
$-0.95
Dividend yield
52W range
$6 – $17
Volume
0.7M

Rxsight Inc (RXST) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+54.2%
Last 4 quarters
Revenue YoY growth
-18.9%
Most recent quarter
EPS YoY growth
-200.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.4%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-4.3%
2025-11-05
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$-0.03+91.1%$7.57$7.39-2.4%
2025-11-05$-0.04+89.5%$9.00$8.61-4.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.34$-0.03+91.1%$32.61M-18.9%
2025-09-30$-0.38$-0.04+89.5%$30.34M-33.2%
2025-06-30$-0.19$-0.29-52.6%$33.64M-3.6%
2025-03-31$-0.27$-0.03+88.9%$37.90M+28.4%
2024-12-31$-0.17$0.03+117.6%$40.21M+40.7%
2024-09-30$-0.25$-0.16+36.0%$45.41M+48.1%
2024-06-30$-0.22$-0.16+27.3%$34.89M+67.6%
2024-03-31$-0.27$-0.25+7.4%$29.51M+68.7%
2023-12-31$-0.36$-0.26+27.8%$28.58M
2023-09-30$-0.43$-0.31+27.9%$30.67M
2023-06-30$-0.47$-0.39+17.0%$20.81M
2023-03-31$-0.53$-0.42+20.8%$17.49M

Frequently asked questions

Has Rxsight Inc beaten earnings estimates?
Rxsight Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +54.2% over the last 4 quarters.
How does RXST stock react to earnings?
RXST stock has moved an average of -3.4% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Rxsight Inc's revenue growth rate?
Rxsight Inc reported year-over-year revenue growth of -18.9% in its most recent quarter, with EPS growing -200.0% year-over-year.